About Independent Public Teaching Hospital No. 4 In Lublin
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Genzyme, a Sanofi Company
2
Ionis Pharmaceuticals, Inc.
1
Clinical Trials at Independent Public Teaching Hospital No. 4 In Lublin
During the past decade, Independent Public Teaching Hospital No. 4 In Lublin conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel
2010-11-01
2013-01-01
Completed
116
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Independent Public Teaching Hospital No. 4 In Lublin"
#1 collaborator was "Bayer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Independent Public Teaching Hospital No. 4 In Lublin
According to Clinical.Site data, the most researched conditions in "Independent Public Teaching Hospital No. 4 In Lublin" are
"Multiple Sclerosis, Relapsing-Remitting" (2 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Independent Public Teaching Hospital No. 4 In Lublin" in a lesser frequency.
Clinical Trials Intervention Types at Independent Public Teaching Hospital No. 4 In Lublin
Most popular intervention types in "Independent Public Teaching Hospital No. 4 In Lublin" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Interferon beta-1a" (2 trials), "Alemtuzumab" (1 trials), "Alemtuzumab 12 mg" (1 trials), "Alemtuzumab 24 mg" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Independent Public Teaching Hospital No. 4 In Lublin
The vast majority of trials in "Independent Public Teaching Hospital No. 4 In Lublin" are
3 trials for "All" genders.
Clinical Trials Status at Independent Public Teaching Hospital No. 4 In Lublin
Currently, there are NaN active trials in "Independent Public Teaching Hospital No. 4 In Lublin".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Independent Public Teaching Hospital No. 4 In Lublin,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Independent Public Teaching Hospital No. 4 In Lublin, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".